Ryan J. Watts - 06 Jan 2026 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
President and CEO, Director
Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
06 Jan 2026
Net transactions value
-$580,767
Form type
4
Filing time
08 Jan 2026, 16:20:05 UTC
Previous filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Watts Ryan J. President and CEO, Director C/O DENALI THERAPEUTICS INC., 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO /s/ Tyler Nielsen, by power of attorney 08 Jan 2026 0001724310

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale $580,767 -35,198 -11% $16.50 296,833 06 Jan 2026 Direct F1, F2
holding DNLI Common Stock 2,152,604 06 Jan 2026 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.
F2 Includes 184,915 Unvested RSUs.
F3 The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.